Introduction
The alkaline metal lithium affects various developmental and physiological processes in evolutionarily diverse organisms (Phiel and Klein, 2001 ). In particular, lithium's actions in the nervous system have attracted special attention because lithium is highly effective in the prophylaxis and treatment of bipolar affective disorder (Schou, 2001 ). In addition, recent studies suggest that chronic lithium treatment is efficacious in preventing apoptosisdependent neuronal death (Chuang, 2004) , which raises the interesting possibility that lithium might be effective in treating or preventing brain damage, either following injury or over the course of progression of neurodegenerative diseases. Despite the proven clinical usefulness and the further potential of this drug, the molecular mechanisms underlying its actions in the nervous system are still only poorly understood.
At therapeutically relevant concentrations, lithium inhibits several enzymes, including glycogen synthase kinase 3b (GSK3b) as well as inositol monophosphatase (IMPase) and related enzymes (Berridge et al., 1989; Klein and Melton, 1996) . These lithium-sensitive enzymes are intimately involved in the regulation of various intracellular molecular cascades, such as the Wnt and inositol phosphate signaling pathways (Chen et al., 2000; Ding et al., 2000) . Lithium-based perturbation of these signaling pathways has a significant impact on global gene expression profiles (Rowe and Chuang, 2004) , and this may contribute to the therapeutic as well as toxic actions of lithium. In order to elucidate the importance of gene regulation in lithium's actions in the nervous system, we need to identify genes whose expression is influenced by therapeutic concentrations of lithium, and to study their roles in the lithiumresponsive neurobiological processes at the molecular, cellular and organismal levels.
The fruit fly Drosophila melanogaster has been a valuable genetic model system for examining fundamental problems in neurobiology. In part, this is due to the fact that Drosophila and higher vertebrates share genetic pathways for cellular signaling (Miklos and Rubin, 1996; Rubin et al., 2000) . In addition, many human genes involved in brain functions and neurological disorders have fly counterparts (Reiter et al., 2001; Davis, 2005; Hamet and Tremblay, 2006) . Importantly, the genetic pathways involved in lithium's actions in the nervous system appear to be shared by Drosophila and vertebrates. For example, the administration of lithium to fruit flies and vertebrates has a similar effect on circadian clocks, and in both cases this effect involves the To gain insight into the basic neurobiological processes regulated by lithium-an effective drug for bipolar disorder-we used Affymetrix Genome Arrays to examine lithium-induced changes in genomewide gene expression profiles of head mRNA from the genetic model organism Drosophila melanogaster. First, to identify the individual genes whose transcript levels are most significantly altered by lithium, we analyzed the microarray data with stringent criteria (fold change > 2; p < 0.001) and evaluated the results by RT-PCR. This analysis identified 12 genes that encode proteins with various biological functions, including an enzyme responsible for amino acid metabolism and a putative amino acid transporter. Second, to uncover the biological pathways involved in lithium's action in the nervous system, we used less stringent criteria (fold change > 1.2; FDR < 0.05) and assigned the identified 66 lithium-responsive genes to biological pathways using DAVID (Database for Annotation, Visualization and Integrated Discovery). The gene ontology categories most significantly affected by lithium were amino acid metabolic processes. Taken together, these data suggest that amino acid metabolism is important for lithium's actions in the nervous system, and lay a foundation for future functional studies of lithium-responsive neurobiological processes using the versatile molecular and genetic tools that are available in Drosophila.
ß 2009 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
